ReP USP - Resultado da busca

Artigo de periodico
Establishment of Psychotria viridis Ruiz & Pav. callus cultures, plantlet regeneration and in vitro production of the hallucinogenic indole alkaloid N,N-dimethyltryptamine (2025)
Andrade, Camila Moreno Lopes de ; Bismara, Beatriz Aparecida Passos Paranhos ; Santos, Fabiana Pereira; Yonamine, Maurício ; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Alves, Fernando Henrique Ferrari ; Pasqual, Moacir ; Stein, Vanessa Cristina
Source: Plant Cell, Tissue and Organ Culture (PCTOC). Unidades: FCF, FMRP
Subjects: ALUCINOGÊNICOS, PLÂNTULAS, ALCALOIDES, CULTURA DE TECIDOS VEGETAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Camila Moreno Lopes de et al. Establishment of Psychotria viridis Ruiz & Pav. callus cultures, plantlet regeneration and in vitro production of the hallucinogenic indole alkaloid N,N-dimethyltryptamine. Plant Cell, Tissue and Organ Culture (PCTOC), v. 161, n. 65, p. 1-16, 2025Tradução . . Disponível em: https://dx.doi.org/10.1007/s11240-025-03061-y. Acesso em: 27 nov. 2025.
APA
Andrade, C. M. L. de, Bismara, B. A. P. P., Santos, F. P., Yonamine, M., Crippa, J. A. de S., Hallak, J. E. C., et al. (2025). Establishment of Psychotria viridis Ruiz & Pav. callus cultures, plantlet regeneration and in vitro production of the hallucinogenic indole alkaloid N,N-dimethyltryptamine. Plant Cell, Tissue and Organ Culture (PCTOC), 161( 65), 1-16. doi:10.1007/s11240-025-03061-y
NLM
Andrade CML de, Bismara BAPP, Santos FP, Yonamine M, Crippa JA de S, Hallak JEC, Alves FHF, Pasqual M, Stein VC. Establishment of Psychotria viridis Ruiz & Pav. callus cultures, plantlet regeneration and in vitro production of the hallucinogenic indole alkaloid N,N-dimethyltryptamine [Internet]. Plant Cell, Tissue and Organ Culture (PCTOC). 2025 ; 161( 65): 1-16.[citado 2025 nov. 27 ] Available from: https://dx.doi.org/10.1007/s11240-025-03061-y
Vancouver
Andrade CML de, Bismara BAPP, Santos FP, Yonamine M, Crippa JA de S, Hallak JEC, Alves FHF, Pasqual M, Stein VC. Establishment of Psychotria viridis Ruiz & Pav. callus cultures, plantlet regeneration and in vitro production of the hallucinogenic indole alkaloid N,N-dimethyltryptamine [Internet]. Plant Cell, Tissue and Organ Culture (PCTOC). 2025 ; 161( 65): 1-16.[citado 2025 nov. 27 ] Available from: https://dx.doi.org/10.1007/s11240-025-03061-y
Artigo de periodico
Antinociceptive action of cannabidiol on thermal sensitivity and post-operative pain in male and female rats (2024)
Arantes, Ana Luisa Ferreira; Carvalho, Milene Cristina de ; Brandão, Marcus Lira ; Prado, William Alves do; Crippa, José Alexandre de Souza ; Lovick, Thelma Anderson; Genaro, Karina
Source: Behavioural Brain Research. Unidades: FMRP, FFCLRP
Subjects: CANABINOIDES, ANTICONCEPÇÃO, RATOS WISTAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARANTES, Ana Luisa Ferreira et al. Antinociceptive action of cannabidiol on thermal sensitivity and post-operative pain in male and female rats. Behavioural Brain Research, v. 459, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2023.114793. Acesso em: 27 nov. 2025.
APA
Arantes, A. L. F., Carvalho, M. C. de, Brandão, M. L., Prado, W. A. do, Crippa, J. A. de S., Lovick, T. A., & Genaro, K. (2024). Antinociceptive action of cannabidiol on thermal sensitivity and post-operative pain in male and female rats. Behavioural Brain Research, 459. doi:10.1016/j.bbr.2023.114793
NLM
Arantes ALF, Carvalho MC de, Brandão ML, Prado WA do, Crippa JA de S, Lovick TA, Genaro K. Antinociceptive action of cannabidiol on thermal sensitivity and post-operative pain in male and female rats [Internet]. Behavioural Brain Research. 2024 ; 459[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.bbr.2023.114793
Vancouver
Arantes ALF, Carvalho MC de, Brandão ML, Prado WA do, Crippa JA de S, Lovick TA, Genaro K. Antinociceptive action of cannabidiol on thermal sensitivity and post-operative pain in male and female rats [Internet]. Behavioural Brain Research. 2024 ; 459[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.bbr.2023.114793
Artigo de periodico
Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission (2024)
Pedrazzi, João Francisco Cordeiro; Amaral, Danyelle Silva; Issy, Ana C.; Gomes, Felipe Villela ; Crippa, José Alexandre de Souza ; Guimarães, Francisco Silveira ; Del Bel, Elaine Aparecida
Source: Pharmacology Biochemistry and Behavior. Unidades: FMRP, FORP
Subjects: CANABINOIDES, NEUROTRANSMISSORES, ESQUIZOFRENIA, ANTIPSICÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRAZZI, João Francisco Cordeiro et al. Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission. Pharmacology Biochemistry and Behavior, v. 245, p. 1-9, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.pbb.2024.173879. Acesso em: 27 nov. 2025.
APA
Pedrazzi, J. F. C., Amaral, D. S., Issy, A. C., Gomes, F. V., Crippa, J. A. de S., Guimarães, F. S., & Del Bel, E. A. (2024). Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission. Pharmacology Biochemistry and Behavior, 245, 1-9. doi:10.1016/j.pbb.2024.173879
NLM
Pedrazzi JFC, Amaral DS, Issy AC, Gomes FV, Crippa JA de S, Guimarães FS, Del Bel EA. Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission [Internet]. Pharmacology Biochemistry and Behavior. 2024 ; 245 1-9.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.pbb.2024.173879
Vancouver
Pedrazzi JFC, Amaral DS, Issy AC, Gomes FV, Crippa JA de S, Guimarães FS, Del Bel EA. Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission [Internet]. Pharmacology Biochemistry and Behavior. 2024 ; 245 1-9.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.pbb.2024.173879
Artigo de periodico
Lack of acute agomelatine effect in a model of social anxiety in healthy volunteers (2024)
Santos, Rafael Guimarães dos ; Dias, Isabella Caroline da Silva ; Zuardi, Antônio Waldo ; Queiroz, Regina Helena Costa; Guimarães, Francisco Silveira ; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza
Source: Journal of Clinical Psychopharmacology. Unidades: FMRP, FCFRP
Subjects: ANSIEDADE SOCIAL, ANTIDEPRESSIVOS, FÁRMACOS PSICOTRÓPICOS, PLACEBOS, ENSAIO CLÍNICO, VOLUNTARISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos et al. Lack of acute agomelatine effect in a model of social anxiety in healthy volunteers. Journal of Clinical Psychopharmacology, v. 44, n. 5, p. 472-480, 2024Tradução . . Disponível em: https://doi.org/10.1097/JCP.0000000000001888. Acesso em: 27 nov. 2025.
APA
Santos, R. G. dos, Dias, I. C. da S., Zuardi, A. W., Queiroz, R. H. C., Guimarães, F. S., Hallak, J. E. C., & Crippa, J. A. de S. (2024). Lack of acute agomelatine effect in a model of social anxiety in healthy volunteers. Journal of Clinical Psychopharmacology, 44( 5), 472-480. doi:10.1097/JCP.0000000000001888
NLM
Santos RG dos, Dias IC da S, Zuardi AW, Queiroz RHC, Guimarães FS, Hallak JEC, Crippa JA de S. Lack of acute agomelatine effect in a model of social anxiety in healthy volunteers [Internet]. Journal of Clinical Psychopharmacology. 2024 ; 44( 5): 472-480.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1097/JCP.0000000000001888
Vancouver
Santos RG dos, Dias IC da S, Zuardi AW, Queiroz RHC, Guimarães FS, Hallak JEC, Crippa JA de S. Lack of acute agomelatine effect in a model of social anxiety in healthy volunteers [Internet]. Journal of Clinical Psychopharmacology. 2024 ; 44( 5): 472-480.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1097/JCP.0000000000001888
Artigo de periodico
Cannabigerol mitigates haloperidol-induced vacuous chewing movements in mice (2024)
Moraes, Rafaela Aparecida Ponciano da Silva de; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Guimarães, Francisco Silveira ; Del Bel, Elaine Aparecida
Source: Neurotoxicity Research. Unidades: FMRP, FORP
Subjects: CANABINOIDES, MASTIGAÇÃO, NEURÓGLIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAES, Rafaela Aparecida Ponciano da Silva de et al. Cannabigerol mitigates haloperidol-induced vacuous chewing movements in mice. Neurotoxicity Research, v. 43, n. 1, p. 1-12, 2024Tradução . . Disponível em: https://doi.org/10.1007/s12640-024-00724-0. Acesso em: 27 nov. 2025.
APA
Moraes, R. A. P. da S. de, Hallak, J. E. C., Crippa, J. A. de S., Guimarães, F. S., & Del Bel, E. A. (2024). Cannabigerol mitigates haloperidol-induced vacuous chewing movements in mice. Neurotoxicity Research, 43( 1), 1-12. doi:10.1007/s12640-024-00724-0
NLM
Moraes RAP da S de, Hallak JEC, Crippa JA de S, Guimarães FS, Del Bel EA. Cannabigerol mitigates haloperidol-induced vacuous chewing movements in mice [Internet]. Neurotoxicity Research. 2024 ; 43( 1): 1-12.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1007/s12640-024-00724-0
Vancouver
Moraes RAP da S de, Hallak JEC, Crippa JA de S, Guimarães FS, Del Bel EA. Cannabigerol mitigates haloperidol-induced vacuous chewing movements in mice [Internet]. Neurotoxicity Research. 2024 ; 43( 1): 1-12.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1007/s12640-024-00724-0
Parte de monografia/livro
Therapeutic potential of CBD in Autism Spectrum Disorder (2024)
Pedrazzi, João Francisco Cordeiro; Camina, Lucas Hassib ; Ferreira, Frederico R.; Hallak, Jaime Eduardo Cecilio ; Del Bel, Elaine Aparecida ; Crippa, José Alexandre de Souza
Source: International review of neurobiology: cannabidiol in neurology and psychiatry. Unidades: FMRP, FORP
Subjects: TRANSTORNO DO ESPECTRO AUTISTA, CANABINOIDES, ENSAIO CLÍNICO, FARMACOLOGIA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRAZZI, João Francisco Cordeiro et al. Therapeutic potential of CBD in Autism Spectrum Disorder. International review of neurobiology: cannabidiol in neurology and psychiatry. Tradução . London: 10.1016/bs.irn.2024.05.002, 2024. p. 334 . Disponível em: https://doi.org/10.1016/bs.irn.2024.05.002. Acesso em: 27 nov. 2025.
APA
Pedrazzi, J. F. C., Camina, L. H., Ferreira, F. R., Hallak, J. E. C., Del Bel, E. A., & Crippa, J. A. de S. (2024). Therapeutic potential of CBD in Autism Spectrum Disorder. In International review of neurobiology: cannabidiol in neurology and psychiatry (p. 334 ). London: 10.1016/bs.irn.2024.05.002. doi:10.1016/bs.irn.2024.05.002
NLM
Pedrazzi JFC, Camina LH, Ferreira FR, Hallak JEC, Del Bel EA, Crippa JA de S. Therapeutic potential of CBD in Autism Spectrum Disorder [Internet]. In: International review of neurobiology: cannabidiol in neurology and psychiatry. London: 10.1016/bs.irn.2024.05.002; 2024. p. 334 .[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/bs.irn.2024.05.002
Vancouver
Pedrazzi JFC, Camina LH, Ferreira FR, Hallak JEC, Del Bel EA, Crippa JA de S. Therapeutic potential of CBD in Autism Spectrum Disorder [Internet]. In: International review of neurobiology: cannabidiol in neurology and psychiatry. London: 10.1016/bs.irn.2024.05.002; 2024. p. 334 .[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/bs.irn.2024.05.002
Artigo de periodico
Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study (2024)
Pinto, Jairo Vinicius Merege de Mello Cruz; Crippa, José Alexandre de Souza ; Ceresér, Keila Maria; Vianna-Sulzbach, Miréia Fortes; Silveira Júnior, Érico de Moura; Rosa, Gabriel Santana da; Silva, Manoella Guatimuzim Testa da; Hizo, Gabriel Henrique; Medeiros, Leonardo Simão; Oliveira, Carlos Eduardo Santana de; Bristot, Giovana; Campos, Alline Cristina de ; Guimarães, Francisco Silveira ; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antônio Waldo ; Yatham, Lakshmi N.; Kapczinski, Flávio; Kauer-Sant’anna, Márcia
Source: The Canadian Journal of Psychiatry. Unidades: FMRP, ESALQ
Subjects: TRANSTORNO BIPOLAR, HUMOR, DEPRESSÃO, CANNABIS, CANABINOIDES, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Jairo Vinicius Merege de Mello Cruz et al. Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study. The Canadian Journal of Psychiatry, v. 69, n. 4, p. 242-251, 2024Tradução . . Disponível em: https://doi.org/10.1177/07067437231209650. Acesso em: 27 nov. 2025.
APA
Pinto, J. V. M. de M. C., Crippa, J. A. de S., Ceresér, K. M., Vianna-Sulzbach, M. F., Silveira Júnior, É. de M., Rosa, G. S. da, et al. (2024). Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study. The Canadian Journal of Psychiatry, 69( 4), 242-251. doi:10.1177/07067437231209650
NLM
Pinto JVM de MC, Crippa JA de S, Ceresér KM, Vianna-Sulzbach MF, Silveira Júnior É de M, Rosa GS da, Silva MGT da, Hizo GH, Medeiros LS, Oliveira CES de, Bristot G, Campos AC de, Guimarães FS, Hallak JEC, Zuardi AW, Yatham LN, Kapczinski F, Kauer-Sant’anna M. Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study [Internet]. The Canadian Journal of Psychiatry. 2024 ; 69( 4): 242-251.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1177/07067437231209650
Vancouver
Pinto JVM de MC, Crippa JA de S, Ceresér KM, Vianna-Sulzbach MF, Silveira Júnior É de M, Rosa GS da, Silva MGT da, Hizo GH, Medeiros LS, Oliveira CES de, Bristot G, Campos AC de, Guimarães FS, Hallak JEC, Zuardi AW, Yatham LN, Kapczinski F, Kauer-Sant’anna M. Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study [Internet]. The Canadian Journal of Psychiatry. 2024 ; 69( 4): 242-251.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1177/07067437231209650
Artigo de periodico
Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male mice (2024)
Vaz, Gabriela N.; Turcato, Flávia C.; Lima, Isabel A. V.; Scarante, Franciele F.; Araújo, Melissa Ribeiro de; Brigante, Tamires Amabile Valim ; Rodrigues, Livia C.M.; Guimarães, Francisco Silveira ; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Teixeira, Antonio L.; Oliveira, Antonio C. P.; Campos, Alline Cristina de
Source: IBRO Neuroscience Reports. Unidade: FMRP
Subjects: CAMUNDONGOS, ABLAÇÃO ANIMAL, ANTIDEPRESSIVOS, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VAZ, Gabriela N. et al. Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male mice. IBRO Neuroscience Reports, v. 17, p. 87-95, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.ibneur.2024.06.002. Acesso em: 27 nov. 2025.
APA
Vaz, G. N., Turcato, F. C., Lima, I. A. V., Scarante, F. F., Araújo, M. R. de, Brigante, T. A. V., et al. (2024). Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male mice. IBRO Neuroscience Reports, 17, 87-95. doi:10.1016/j.ibneur.2024.06.002
NLM
Vaz GN, Turcato FC, Lima IAV, Scarante FF, Araújo MR de, Brigante TAV, Rodrigues LCM, Guimarães FS, Hallak JEC, Crippa JA de S, Teixeira AL, Oliveira ACP, Campos AC de. Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male mice [Internet]. IBRO Neuroscience Reports. 2024 ; 17 87-95.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ibneur.2024.06.002
Vancouver
Vaz GN, Turcato FC, Lima IAV, Scarante FF, Araújo MR de, Brigante TAV, Rodrigues LCM, Guimarães FS, Hallak JEC, Crippa JA de S, Teixeira AL, Oliveira ACP, Campos AC de. Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male mice [Internet]. IBRO Neuroscience Reports. 2024 ; 17 87-95.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ibneur.2024.06.002
Artigo de periodico
Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19 (2024)
Ferreira, Rafael R.; Martins, Ronaldo B.; Pires, Isabela Batista ; Marques, Bruno Lemes ; Costa, Karla C.M.; Lirio, Pedro Henrique Cassario ; Scomparin, Davi Silveira ; Scarante, Franciele Franco ; Batah, Sabrina Setembre ; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Rodrigues, Livia C. M. ; Tostes, Rita de Cássia Aleixo ; Fabro, Alexandre Todorovic ; Arruda, Eurico ; Campos, Alline Cristina de
Source: Brain, Behavior, & Immunity - Health. Unidade: FMRP
Subjects: COVID-19, DOENÇAS CARDIOVASCULARES, NEFROPATIAS, INFLAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Rafael R. et al. Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19. Brain, Behavior, & Immunity - Health, v. 41, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.bbih.2024.100855. Acesso em: 27 nov. 2025.
APA
Ferreira, R. R., Martins, R. B., Pires, I. B., Marques, B. L., Costa, K. C. M., Lirio, P. H. C., et al. (2024). Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19. Brain, Behavior, & Immunity - Health, 41. doi:10.1016/j.bbih.2024.100855
NLM
Ferreira RR, Martins RB, Pires IB, Marques BL, Costa KCM, Lirio PHC, Scomparin DS, Scarante FF, Batah SS, Hallak JEC, Crippa JA de S, Rodrigues LCM, Tostes R de CA, Fabro AT, Arruda E, Campos AC de. Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19 [Internet]. Brain, Behavior, & Immunity - Health. 2024 ; 41[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.bbih.2024.100855
Vancouver
Ferreira RR, Martins RB, Pires IB, Marques BL, Costa KCM, Lirio PHC, Scomparin DS, Scarante FF, Batah SS, Hallak JEC, Crippa JA de S, Rodrigues LCM, Tostes R de CA, Fabro AT, Arruda E, Campos AC de. Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19 [Internet]. Brain, Behavior, & Immunity - Health. 2024 ; 41[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.bbih.2024.100855
Parte de monografia/livro
Cannabidiol in anxiety disorders: current and future perspectives (2024)
Simei, João Luís Queiroz; Souza, José Diogo Ribeiro de; Lisboa, João Roberto; Guimarães, Francisco Silveira ; Crippa, José Alexandre de Souza
Source: International review of neurobiology: cannabidiol in neurology and psychiatry. Unidade: FMRP
Subjects: ANSIEDADE, CANABINOIDES, QUALIDADE DE VIDA, NEUROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIMEI, João Luís Queiroz et al. Cannabidiol in anxiety disorders: current and future perspectives. International review of neurobiology: cannabidiol in neurology and psychiatry. Tradução . London: Academic Press, 2024. . Disponível em: https://doi.org/10.1016/bs.irn.2024.05.003. Acesso em: 27 nov. 2025.
APA
Simei, J. L. Q., Souza, J. D. R. de, Lisboa, J. R., Guimarães, F. S., & Crippa, J. A. de S. (2024). Cannabidiol in anxiety disorders: current and future perspectives. In International review of neurobiology: cannabidiol in neurology and psychiatry. London: Academic Press. doi:10.1016/bs.irn.2024.05.003
NLM
Simei JLQ, Souza JDR de, Lisboa JR, Guimarães FS, Crippa JA de S. Cannabidiol in anxiety disorders: current and future perspectives [Internet]. In: International review of neurobiology: cannabidiol in neurology and psychiatry. London: Academic Press; 2024. [citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/bs.irn.2024.05.003
Vancouver
Simei JLQ, Souza JDR de, Lisboa JR, Guimarães FS, Crippa JA de S. Cannabidiol in anxiety disorders: current and future perspectives [Internet]. In: International review of neurobiology: cannabidiol in neurology and psychiatry. London: Academic Press; 2024. [citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/bs.irn.2024.05.003
Trabalho de evento-resumo periodico
Cannabidiol and cannabigerol limit l-dopa-induced dyskinesia when given separately or in combination to hemiparkinsonian rats (2024)
Mattos, Bianca Andretto de; Nascimento, Glauce Crivelaro do ; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Michel, Patrick; Raisman-Vozari, Rita; Guimarães, Francisco Silveira ; Del Bel, Elaine Aparecida
Source: IBRO Neuroscience Reports. Conference titles: World Congress of Neuroscience IBRO. Unidades: FORP, FMRP
Subjects: CANABINOIDES, DOENÇA DE PARKINSON, ANTI-INFLAMATÓRIOS, ANTIOXIDANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATTOS, Bianca Andretto de et al. Cannabidiol and cannabigerol limit l-dopa-induced dyskinesia when given separately or in combination to hemiparkinsonian rats. IBRO Neuroscience Reports. Amsterdam: Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.ibneur.2023.08.675. Acesso em: 27 nov. 2025. , 2024
APA
Mattos, B. A. de, Nascimento, G. C. do, Crippa, J. A. de S., Hallak, J. E. C., Michel, P., Raisman-Vozari, R., et al. (2024). Cannabidiol and cannabigerol limit l-dopa-induced dyskinesia when given separately or in combination to hemiparkinsonian rats. IBRO Neuroscience Reports. Amsterdam: Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.ibneur.2023.08.675
NLM
Mattos BA de, Nascimento GC do, Crippa JA de S, Hallak JEC, Michel P, Raisman-Vozari R, Guimarães FS, Del Bel EA. Cannabidiol and cannabigerol limit l-dopa-induced dyskinesia when given separately or in combination to hemiparkinsonian rats [Internet]. IBRO Neuroscience Reports. 2024 ; 15 S359.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ibneur.2023.08.675
Vancouver
Mattos BA de, Nascimento GC do, Crippa JA de S, Hallak JEC, Michel P, Raisman-Vozari R, Guimarães FS, Del Bel EA. Cannabidiol and cannabigerol limit l-dopa-induced dyskinesia when given separately or in combination to hemiparkinsonian rats [Internet]. IBRO Neuroscience Reports. 2024 ; 15 S359.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ibneur.2023.08.675
Artigo de periodico-carta/editorial
Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial] (2023)
Crippa, José Alexandre de Souza ; Guimarães, Francisco Silveira ; Zuardi, Antônio Waldo ; Hallak, Jaime Eduardo Cecilio
Source: Brazilian Journal of Psychiatry. Unidade: FMRP
Subjects: CANABINOIDES, CANNABIS, ALUCINOGÊNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial]. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.47626/1516-4446-2023-0047. Acesso em: 27 nov. 2025. , 2023
APA
Crippa, J. A. de S., Guimarães, F. S., Zuardi, A. W., & Hallak, J. E. C. (2023). Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial]. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.47626/1516-4446-2023-0047
NLM
Crippa JA de S, Guimarães FS, Zuardi AW, Hallak JEC. Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial] [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 3): 201-202.[citado 2025 nov. 27 ] Available from: https://doi.org/10.47626/1516-4446-2023-0047
Vancouver
Crippa JA de S, Guimarães FS, Zuardi AW, Hallak JEC. Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial] [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 3): 201-202.[citado 2025 nov. 27 ] Available from: https://doi.org/10.47626/1516-4446-2023-0047
Artigo de periodico
Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats (2023)
Cardoso, Gleice Kelli Ribeiro da Silva ; Lopes, Willian Lazarini ; Primini, Eduardo Octaviano; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Zuardi, Antônio Waldo ; Garcia-Cairasco, Norberto ; Leite-Panissi, Christie Ramos Andrade
Source: Behavioural Brain Research. Unidades: FMRP, FFCLRP
Subjects: CANNABIS, DOR CRÔNICA, DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Gleice Kelli Ribeiro da Silva et al. Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats. Behavioural Brain Research, v. 452, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2023.114588. Acesso em: 27 nov. 2025.
APA
Cardoso, G. K. R. da S., Lopes, W. L., Primini, E. O., Hallak, J. E. C., Crippa, J. A. de S., Zuardi, A. W., et al. (2023). Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats. Behavioural Brain Research, 452, 1-16. doi:10.1016/j.bbr.2023.114588
NLM
Cardoso GKR da S, Lopes WL, Primini EO, Hallak JEC, Crippa JA de S, Zuardi AW, Garcia-Cairasco N, Leite-Panissi CRA. Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats [Internet]. Behavioural Brain Research. 2023 ; 452 1-16.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.bbr.2023.114588
Vancouver
Cardoso GKR da S, Lopes WL, Primini EO, Hallak JEC, Crippa JA de S, Zuardi AW, Garcia-Cairasco N, Leite-Panissi CRA. Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats [Internet]. Behavioural Brain Research. 2023 ; 452 1-16.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.bbr.2023.114588
Artigo de periodico
Systemic chronic treatment with cannabidiol in carioca high- and low-conditioned freezing rats in the neuropathic pain model: evaluation of pain sensitivity (2023)
Souza, Carolina Macêdo de; Maisonnette, Sílvia Soares; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Zuardi, Antônio Waldo ; Landeira-Fernandez, J.; Leite-Panissi, Christie Ramos Andrade
Source: Pharmaceuticals. Unidades: FMRP, FFCLRP
Subjects: CANABINOIDES, ANSIEDADE, DOR CRÔNICA, DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Carolina Macêdo de et al. Systemic chronic treatment with cannabidiol in carioca high- and low-conditioned freezing rats in the neuropathic pain model: evaluation of pain sensitivity. Pharmaceuticals, v. 16, n. 7, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.3390/ph16071003. Acesso em: 27 nov. 2025.
APA
Souza, C. M. de, Maisonnette, S. S., Hallak, J. E. C., Crippa, J. A. de S., Zuardi, A. W., Landeira-Fernandez, J., & Leite-Panissi, C. R. A. (2023). Systemic chronic treatment with cannabidiol in carioca high- and low-conditioned freezing rats in the neuropathic pain model: evaluation of pain sensitivity. Pharmaceuticals, 16( 7), 1-15. doi:10.3390/ph16071003
NLM
Souza CM de, Maisonnette SS, Hallak JEC, Crippa JA de S, Zuardi AW, Landeira-Fernandez J, Leite-Panissi CRA. Systemic chronic treatment with cannabidiol in carioca high- and low-conditioned freezing rats in the neuropathic pain model: evaluation of pain sensitivity [Internet]. Pharmaceuticals. 2023 ; 16( 7): 1-15.[citado 2025 nov. 27 ] Available from: https://doi.org/10.3390/ph16071003
Vancouver
Souza CM de, Maisonnette SS, Hallak JEC, Crippa JA de S, Zuardi AW, Landeira-Fernandez J, Leite-Panissi CRA. Systemic chronic treatment with cannabidiol in carioca high- and low-conditioned freezing rats in the neuropathic pain model: evaluation of pain sensitivity [Internet]. Pharmaceuticals. 2023 ; 16( 7): 1-15.[citado 2025 nov. 27 ] Available from: https://doi.org/10.3390/ph16071003
Artigo de periodico
Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021) (2023)
Osório, Flávia de Lima ; Zuardi, Antônio Waldo ; Silveira, Isabella Lara Machado ; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Pereira-Lima, Karina ; Loureiro, Sonia Regina
Source: Frontiers in Psychiatry. Unidade: FMRP
Subjects: COVID-19, SAÚDE MENTAL, ANSIEDADE, ESTRESSE PROFISSIONAL, PROFISSIONAIS DA SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OSÓRIO, Flávia de Lima et al. Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021). Frontiers in Psychiatry, v. 14, p. 1-8, 2023Tradução . . Disponível em: https://doi.org/10.3389/fpsyt.2023.1026429. Acesso em: 27 nov. 2025.
APA
Osório, F. de L., Zuardi, A. W., Silveira, I. L. M., Crippa, J. A. de S., Hallak, J. E. C., Pereira-Lima, K., & Loureiro, S. R. (2023). Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021). Frontiers in Psychiatry, 14, 1-8. doi:10.3389/fpsyt.2023.1026429
NLM
Osório F de L, Zuardi AW, Silveira ILM, Crippa JA de S, Hallak JEC, Pereira-Lima K, Loureiro SR. Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021) [Internet]. Frontiers in Psychiatry. 2023 ; 14 1-8.[citado 2025 nov. 27 ] Available from: https://doi.org/10.3389/fpsyt.2023.1026429
Vancouver
Osório F de L, Zuardi AW, Silveira ILM, Crippa JA de S, Hallak JEC, Pereira-Lima K, Loureiro SR. Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021) [Internet]. Frontiers in Psychiatry. 2023 ; 14 1-8.[citado 2025 nov. 27 ] Available from: https://doi.org/10.3389/fpsyt.2023.1026429
Artigo de periodico
Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study (2023)
Loureiro, Sonia Regina ; Zuardi, Antônio Waldo ; Silveira, Isabella Lara Machado ; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Osório, Flávia de Lima
Source: Frontiers in Psychiatry. Unidade: FMRP
Subjects: SAÚDE MENTAL, OCUPAÇÕES EM SAÚDE, ESTUDOS LONGITUDINAIS, PANDEMIAS, COVID-19, ESTRESSE PROFISSIONAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOUREIRO, Sonia Regina et al. Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study. Frontiers in Psychiatry, v. 14, p. 1-8, 2023Tradução . . Disponível em: https://doi.org/10.3389/fpsyt.2023.1237123. Acesso em: 27 nov. 2025.
APA
Loureiro, S. R., Zuardi, A. W., Silveira, I. L. M., Crippa, J. A. de S., Hallak, J. E. C., & Osório, F. de L. (2023). Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study. Frontiers in Psychiatry, 14, 1-8. doi:10.3389/fpsyt.2023.1237123
NLM
Loureiro SR, Zuardi AW, Silveira ILM, Crippa JA de S, Hallak JEC, Osório F de L. Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study [Internet]. Frontiers in Psychiatry. 2023 ; 14 1-8.[citado 2025 nov. 27 ] Available from: https://doi.org/10.3389/fpsyt.2023.1237123
Vancouver
Loureiro SR, Zuardi AW, Silveira ILM, Crippa JA de S, Hallak JEC, Osório F de L. Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study [Internet]. Frontiers in Psychiatry. 2023 ; 14 1-8.[citado 2025 nov. 27 ] Available from: https://doi.org/10.3389/fpsyt.2023.1237123
Artigo de periodico
DNA methylation in regulatory elements of the FKBP5 and NR3C1 gene in mother-child binomials with depression (2023)
Mendonça, Mariana S.; Mangiavacchi, Paula M.; Mendes, Ana V.; Loureiro, Sonia Regina ; Martin-Santos, Rocio ; Glória, Leonardo S.; Marques Júnior, Wilson ; Marco, Silmara Paula Gouvea de ; Kanashiro, Milton M.; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Rios, Álvaro F. L.
Source: Journal of Affective Disorders. Unidade: FMRP
Subjects: DEPRESSÃO, METILAÇÃO DE DNA, EPIGÊNESE GENÉTICA, GRAVIDEZ, RECEPTORES DE GLICOCORTICOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENDONÇA, Mariana S. et al. DNA methylation in regulatory elements of the FKBP5 and NR3C1 gene in mother-child binomials with depression. Journal of Affective Disorders, v. 331, p. 287-299, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jad.2023.03.031. Acesso em: 27 nov. 2025.
APA
Mendonça, M. S., Mangiavacchi, P. M., Mendes, A. V., Loureiro, S. R., Martin-Santos, R., Glória, L. S., et al. (2023). DNA methylation in regulatory elements of the FKBP5 and NR3C1 gene in mother-child binomials with depression. Journal of Affective Disorders, 331, 287-299. doi:10.1016/j.jad.2023.03.031
NLM
Mendonça MS, Mangiavacchi PM, Mendes AV, Loureiro SR, Martin-Santos R, Glória LS, Marques Júnior W, Marco SPG de, Kanashiro MM, Hallak JEC, Crippa JA de S, Rios ÁFL. DNA methylation in regulatory elements of the FKBP5 and NR3C1 gene in mother-child binomials with depression [Internet]. Journal of Affective Disorders. 2023 ; 331 287-299.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.jad.2023.03.031
Vancouver
Mendonça MS, Mangiavacchi PM, Mendes AV, Loureiro SR, Martin-Santos R, Glória LS, Marques Júnior W, Marco SPG de, Kanashiro MM, Hallak JEC, Crippa JA de S, Rios ÁFL. DNA methylation in regulatory elements of the FKBP5 and NR3C1 gene in mother-child binomials with depression [Internet]. Journal of Affective Disorders. 2023 ; 331 287-299.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.jad.2023.03.031
Artigo de periodico
Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus (2023)
Chaves, Yane Costa; Raymundi, Ana Maria; Waltrick, Ana Paula Farias ; Crippa, José Alexandre de Souza ; Stern, Cristina Aparecida Jark; Cunha, Joice Maria da; Zanoveli, Janaina Menezes
Source: Acta Neuropsychiatrica. Unidade: FMRP
Subjects: ANSIEDADE, MEDO, CANNABIS, MEMÓRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAVES, Yane Costa et al. Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus. Acta Neuropsychiatrica, 2023Tradução . . Disponível em: https://doi.org/10.1017/neu.2023.13. Acesso em: 27 nov. 2025.
APA
Chaves, Y. C., Raymundi, A. M., Waltrick, A. P. F., Crippa, J. A. de S., Stern, C. A. J., Cunha, J. M. da, & Zanoveli, J. M. (2023). Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus. Acta Neuropsychiatrica. doi:10.1017/neu.2023.13
NLM
Chaves YC, Raymundi AM, Waltrick APF, Crippa JA de S, Stern CAJ, Cunha JM da, Zanoveli JM. Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus [Internet]. Acta Neuropsychiatrica. 2023 ;[citado 2025 nov. 27 ] Available from: https://doi.org/10.1017/neu.2023.13
Vancouver
Chaves YC, Raymundi AM, Waltrick APF, Crippa JA de S, Stern CAJ, Cunha JM da, Zanoveli JM. Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus [Internet]. Acta Neuropsychiatrica. 2023 ;[citado 2025 nov. 27 ] Available from: https://doi.org/10.1017/neu.2023.13
Artigo de periodico
Cannabidiol recovers dopaminergic neuronal damage induced by reserpine or α synuclein in Caenorhabditis elegans (2023)
Guedes, Erika da Cruz; Erustes, Adolfo Garcia; Leão, Anderson H. F. F; Carneiro, César Alves; Abílio, Vanessa C; Zuardi, Antônio Waldo ; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Bincoletto, Cláudia; Smaili, Soraya S; Reckziegel, Patricia ; Pereira, Gustavo J. S
Source: Neurochemical Research. Unidades: FCF, FMRP
Subjects: CANABINOIDES, CAENORHABDITIS, DOENÇA DE PARKINSON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUEDES, Erika da Cruz et al. Cannabidiol recovers dopaminergic neuronal damage induced by reserpine or α synuclein in Caenorhabditis elegans. Neurochemical Research, v. 48, n. 8, p. 2390–2405, 2023Tradução . . Disponível em: https://dx.doi.org/10.1007/s11064-023-03905-z. Acesso em: 27 nov. 2025.
APA
Guedes, E. da C., Erustes, A. G., Leão, A. H. F. F., Carneiro, C. A., Abílio, V. C., Zuardi, A. W., et al. (2023). Cannabidiol recovers dopaminergic neuronal damage induced by reserpine or α synuclein in Caenorhabditis elegans. Neurochemical Research, 48( 8), 2390–2405. doi:10.1007/s11064-023-03905-z
NLM
Guedes E da C, Erustes AG, Leão AHFF, Carneiro CA, Abílio VC, Zuardi AW, Hallak JEC, Crippa JA de S, Bincoletto C, Smaili SS, Reckziegel P, Pereira GJS. Cannabidiol recovers dopaminergic neuronal damage induced by reserpine or α synuclein in Caenorhabditis elegans [Internet]. Neurochemical Research. 2023 ; 48( 8): 2390–2405.[citado 2025 nov. 27 ] Available from: https://dx.doi.org/10.1007/s11064-023-03905-z
Vancouver
Guedes E da C, Erustes AG, Leão AHFF, Carneiro CA, Abílio VC, Zuardi AW, Hallak JEC, Crippa JA de S, Bincoletto C, Smaili SS, Reckziegel P, Pereira GJS. Cannabidiol recovers dopaminergic neuronal damage induced by reserpine or α synuclein in Caenorhabditis elegans [Internet]. Neurochemical Research. 2023 ; 48( 8): 2390–2405.[citado 2025 nov. 27 ] Available from: https://dx.doi.org/10.1007/s11064-023-03905-z
Artigo de periodico-carta/editorial
Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups (2023)
Zuardi, Antônio Waldo ; Crippa, José Alexandre de Souza
Source: Brazilian Journal of Psychiatry. Unidade: FMRP
Subjects: ANTICONVULSIVANTES, CANNABIS, CONVULSÕES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZUARDI, Antônio Waldo e CRIPPA, José Alexandre de Souza. Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.47626/1516-4446-2023-3377. Acesso em: 27 nov. 2025. , 2023
APA
Zuardi, A. W., & Crippa, J. A. de S. (2023). Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.47626/1516-4446-2023-3377
NLM
Zuardi AW, Crippa JA de S. Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 6): 463-464.[citado 2025 nov. 27 ] Available from: https://doi.org/10.47626/1516-4446-2023-3377
Vancouver
Zuardi AW, Crippa JA de S. Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 6): 463-464.[citado 2025 nov. 27 ] Available from: https://doi.org/10.47626/1516-4446-2023-3377

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration